Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$230.71 - $256.74 $8,074 - $8,985
35 Added 9.92%
388 $94,000
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $29,382 - $32,504
-134 Reduced 27.52%
353 $85,000
Q4 2021

Feb 15, 2022

BUY
$198.88 - $227.6 $16,904 - $19,346
85 Added 21.14%
487 $110,000
Q1 2021

May 18, 2021

BUY
$221.91 - $258.6 $20,859 - $24,308
94 Added 30.52%
402 $100,000
Q4 2020

Feb 09, 2021

BUY
$216.38 - $257.67 $57,340 - $68,282
265 Added 616.28%
308 $71,000
Q4 2019

Feb 14, 2020

SELL
$189.21 - $243.2 $193,940 - $249,280
-1,025 Reduced 95.97%
43 $10,000
Q3 2019

Nov 15, 2019

SELL
$174.11 - $208.62 $40,567 - $48,608
-233 Reduced 17.91%
1,068 $207,000
Q2 2019

Aug 12, 2019

SELL
$166.7 - $195.41 $11,168 - $13,092
-67 Reduced 4.9%
1,301 $240,000
Q1 2019

Jul 15, 2019

SELL
$180.87 - $203.88 $23,513 - $26,504
-130 Reduced 8.68%
1,368 $260,000
Q4 2018

Feb 13, 2019

BUY
$178.4 - $208.25 $66,008 - $77,052
370 Added 32.8%
1,498 $292,000
Q3 2018

Nov 15, 2018

BUY
$185.29 - $208.89 $209,007 - $235,627
1,128 New
1,128 $209,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Vectors Research Management, LLC Portfolio

Follow Vectors Research Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vectors Research Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vectors Research Management, LLC with notifications on news.